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Abstract
Background
Autonomic dysfunction is a risk factor for cardiovascular disease (CVD), however, the exact
mechanism linking autonomic dysfunction to cardiovascular disease is not known. In this
study we hypothesized that autonomic dysfunction increases inflammation, which subse-
quently accelerates atherosclerosis. The aim of the current study was to investigate the
association between autonomic tone, inflammation and atherosclerosis.
Methods
124 men under investigation for carotid atherosclerosis were examined for autonomic
function (heart rate variability; HRV and baroreflex sensitivity; BRS), inflammatory
markers (white blood cell count; WBCC and C-reactive protein; CRP) and degree of
carotid atherosclerosis. The direct or indirect associations between autonomic function,
inflammatory parameters and carotid plaque area were investigated with multiple linear
regressions.
Results
Male subjects with prevalent CVD showed larger carotid plaque area, higher WBCC, and
reduced BRS compared to subjects with no history of CVD. Further, BRS was inversely
associated with carotid plaque area (r = -0.21, p = 0.018) as well as inflammatory parame-
ters WBCC and CRP (r = -0.29, p = 0.001, and r = -0.23, p = 0.009, respectively), whereas
HRV only was inversely associated with WBCC (r = -0.22, p = 0.014). To investigate if
inflammation could provide a link between autonomic function and carotid atherosclerosis
we adjusted the associations accordingly. After adjusting for WBCC and CRP the inverse
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association between BRS and carotid plaque area was attenuated and did not remain signif-
icant, while both WBCC and CRP remained significantly associated with carotid plaque
area, indicating that low-grade inflammation can possibly link BRS to atherosclerosis. Also,
after adjusting for age, antihypertensive treatment and cardiovascular risk factors, BRS was
independently inversely associated with both WBCC and CRP, and HRV independently
inversely associated with WBCC. WBCC was the only inflammatory marker independently
associated with carotid plaque area after adjustment.
Conclusions
We demonstrate that autonomic dysfunction is associated with atherosclerosis and that
inflammation could play an important role in mediating this relationship.
Introduction
Autonomic dysfunction is associated with increased risk of cardiovascular disease (CVD) and
mortality [1, 2]. Autonomic dysfunction has also been associated with increased atherosclero-
sis, the main underlying cause of CVD [3]. The mechanisms linking the autonomic imbalance
to atherosclerosis are still elusive. Recent studies suggest an association between autonomic
function and inflammation in patients with CVD, showing an inverse relationship between
autonomic activity, measured by heart rate variability (HRV), and plasma levels of inflamma-
tory markers [4–7]. HRV is a well-established and widely used approach to measure auto-
nomic function in humans and represents the time differences between successive heartbeats
[8]. However, other measures of autonomic tone like baroreflex sensitivity, assessed by analyz-
ing the relationship between fluctuations in blood pressure and corresponding changes in RR
intervals, have been poorly assessed for inflammatory associations and needs to be further
investigated.
Inflammation is a key mediator in the pathophysiology of atherosclerosis involving both
the innate and the adaptive immune system [9, 10]. Further, inflammatory markers such as
white blood cell count (WBCC) and C-reactive protein (CRP) can predict CVD [11–13], and
have been associated with atherosclerosis [14–20]. In line with this, the prevalence of CVD is
known to be higher in subjects with autoimmune disorders, like systemic lupus erythematosus
and rheumatoid arthritis [21, 22]. Given this background we hypothesize that inflammation
can be a mediator in the link between autonomic dysfunction and atherosclerosis, leading to
CVD like stroke and myocardial infarction. Few studies have investigated the whole pathway
(autonomic tone—inflammation—atherosclerosis) in the same population, or measured
carotid atherosclerosis as the primary end-point.
We hypothesized that reduced autonomic function will increase low-grade inflamma-
tion, subsequently worsening the progression of atherosclerosis. The aim of the current
study was therefor to investigate if there is a relationship between autonomic function,
assessed by both HRV and BRS, the inflammatory markers CRP and WBCC, and carotid
plaque area in men undergoing investigation for carotid plaques. Further, we aimed to
investigate if inflammation may be a linking mechanism between autonomic dysfunction
and atherosclerosis.
Autonomic function, inflammation and atherosclerosis
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Materials and methods
Study population
The participants were consecutively recruited from the “The Western Region Initiative to
Gather Information on Atherosclerosis” (WINGA) population on the basis that they were
males and 40 years old. The WINGA population provides patient records of all patients
undergoing clinical diagnostic carotid ultrasound examinations within the Greater Gothen-
burg region in Sweden due to any symptoms, i.e. sudden paralysis, numbness, loss of speech,
loss of vision, dizziness or severe and unusual headache. Inclusion criteria were successful
assessment of autonomic function, plasma levels of C-reactive protein (CRP) 10 mg/L and
white blood cell count (WBCC) 30 cells 109/L. Subjects with rheumatoid disease were
excluded. Applying above mentioned criteria, a total of 124 subjects were enrolled. The study
protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and approval
was obtained from the Regional Ethics Committee in Gothenburg. All patients gave written
informed consent to participate.
Baseline characteristics
Subjects were invited to the laboratory and detailed clinical and life style data were collected
using a standardized questionnaire. Data on anthropometry and blood pressure were collected
and venous blood samples were drawn. Inflammatory status was evaluated by measuring
WBCC and high-sensitivity CRP.
Measurement of carotid plaque area
Plaque area was assessed by 2D ultrasound in the common carotid artery (CCA), the carotid
bulb and the proximal section of the internal carotid artery (ICA), bilaterally, as previously
described [23]. Plaques were defined according to the Mannheim consensus [24]. Images were
obtained of each atherosclerotic plaque and they were semi-automatically outlined and mea-
sured using a dedicated software [23]. Re-reading reproducibility of plaque size (n = 45)
showed high correlation coefficients for the right and left carotid arteries (rs = 0.96 and
rs = 0.96, respectively)[25].
Assessment of autonomic function
Autonomic function was assessed by measuring heart rate variability and baroreflex sensitivity
in subjects.
Heart rate variability (SDNN). A 3-lead electrocardiographic (ECG) recording was per-
formed in supine position for 20 minutes with Biopac Pro 3.7 software (BIOPAC Systems Inc,
Goleta, CA, USA). Time domain analysis on the standard deviation (SD) between normal to
normal RR -intervals in the ECG-recording (SDNN) was derived with the Baro Reflex Analysis
(BRA) software (Ekman Biomedical Data AB, Gothenburg, Sweden). SDNN reflects both sym-
pathetic and parasympathetic variability during the time of recording [8].
Baroreflex sensitivity (Slope). Continuous recordings of blood pressure were made with
the sequence method [26] using The CNAP™ Monitor 500 (CNSystems Medizintechnik AG,
Graz, Austria) and Biopac PRO 3.7 software (BIOPAC Systems Inc) over a period of 20 min-
utes with the ECG recording simultaneously. A baroreflex sequence was defined as 3 consecu-
tive beats when the RR interval follows an increase or decrease in the systolic blood pressure,
with the threshold set at 5 ms and 1 mmHg, respectively. A linear regression was applied to
sequences, and correlation coefficients with r>0.92 were accepted. A mean slope was calcu-
lated from the average of qualified sequences.
Autonomic function, inflammation and atherosclerosis
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A limit of 5 percent data loss in both HRV and BRS analysis was used as exclusion criteria.
These kinds of data losses could be technical or biological, such as cardiac arrhythmias.
Statistics
Characteristics between different patient categories were compared using Student´s t-test for
continuous variables and Chi-square test for categorical variables. Normal distribution was
evaluated using Kolmogorov-Smirnov test. BRS Slope, HRV SDNN, CRP, WBCC, carotid pla-
que area, total cholesterol, LDL-cholesterol and HDL-cholesterol were logarithmically trans-
formed due to skewness in distribution. However, untransformed data was presented as
mean ± SD for better comparison with data from other studies.
The association between parameters for autonomic tone (HRV SDNN and BRS Slope), tra-
ditional risk factors for atherosclerosis, inflammatory markers, medical therapy and carotid
plaque area were assessed with correlation (Pearson) analyses. To assess if inflammation could
mediate the association between autonomic function (BRS and HRV) and carotid plaque area,
multiple linear regression models with 2 predictors were used, adjusting for CRP and WBCC
in separate analysis.
Independent associations between parameters for autonomic tone and inflammation, and
between parameters for inflammation and atherosclerosis were assessed with multiple linear
regression, adjusting for medical therapy and clinical factors. Model 1 adjusted for age. Model
2 adjusted for age and antihypertensive medicine. Model 3 was a stepwise adjustment for prev-
alent CVD, current smoker, BMI, diabetes, hypertension, dyslipidemia, systolic blood pressure
and cholesterol-lowering medicine with a selection of p<0.05 for inclusion. Age and antihy-
pertensive medicine were forced into the model.
The analyses were additionally stratified for treatment with statins and differences in
regression slopes evaluated with an interaction term between statins and the main predictor in
the model.
All data was analyzed with SPSS (IBM SPSS Statistics version 24.0, Chicago, IL, USA) and
p<0.05 was considered as the level of significance.
Results
Characteristics of the study population
Analysis was carried out in 124 male subjects undergoing clinical diagnostic carotid ultra-
sound examinations due to any symptoms. 50% of the study subjects had prevalent CVD,
defined as stroke, myocardial infarction or both. The prevalence of subjects ever diagnosed
with hypertension, dyslipidemia or diabetes was 68%, 64% and 15%, respectively. The mean
age was 67 years. Subject characteristics are listed in Table 1.
Comparison between subjects with prevalent CVD and subjects with no
history of CVD
The study population was initially analyzed by comparing variables of inflammation, auto-
nomic function and atherosclerosis in subjects with or without prevalent CVD (n = 62, respec-
tively). Subjects with prevalent CVD showed decreased autonomic function, assessed with
BRS Slope, increased WBCC and larger carotid plaque area, compared to subjects with no his-
tory of CVD (Table 1). However, there was no difference in plasma levels of the inflammatory
marker CRP, or autonomic function assessed by HRV SDNN (Table 1). These data prompted
us to expand the investigation on this interrelationship.
Autonomic function, inflammation and atherosclerosis
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Relationships between autonomic function, inflammation, carotid plaque
area and clinical factors
To investigate possible variables with association to carotid plaque area and inflammatory
markers, univariate correlations were calculated between corresponding parameters and dif-
ferent clinical factors of interest (Table 2). Carotid plaque area showed a positive correlation
with WBCC, CRP, age, prevalent CVD, and antihypertensive medicine whereas BRS Slope was
inversely correlated with carotid plaque area. Investigating predictors of inflammation, CRP
was inversely correlated with BRS Slope and positively correlated with BMI. Further, WBCC
was inversely correlated with BRS Slope and HRV SDNN, and positively correlated with age,
smoking, BMI, prevalent CVD and antihypertensive medicine.
We hypothesized that the association between BRS and atherosclerosis is dependent on
inflammation. Multiple linear regression models with 2 predictors were used to investigate the
direct or indirect associations between inflammatory parameters or BRS and carotid plaque
area (Table 2). The analysis showed that the standardized β-coefficient for BRS Slope, adjusted
for WBCC, was attenuated by 48%, and lost its significance, whereas WBCC was attenuated
Table 1. Characteristics of study population and comparison between subjects with or without prevalent CVD.
Variables Values
All subjects
(n = 124)
No history of
CVD (n = 62)
Prevalent
CVD (n = 62)
p*
Smoking, Yes/No 14/110 4/58 10/52 0.09
Diabetesa, Yes/No 18/106 4/58 14/48 0.011
Dyslipidemiaa, Yes/No 77/44 37/24 40/20 0.7
Hypertensiona, Yes/No 84/39 38/24 46/15 0.1
Cholesterol-lowering medicine Yes/No 64/54 31/29 36/25 0.4
Antihypertensive medicine Yes/No 72/50 31/30 41/20 0.066
Age, years 67.3 ± 8 67 ± 9 68 ± 8 0.7
Carotid plaque area, mm2 58.3 ± 51.6 44.1 ± 40.4 73.0 ± 57.9 <0.001
TC, mg/dL 4.6 ± 1.0 5.0 ± 1.1 4.2 ± 0.8 <0.001
LDL, mg/dL 2.7 ± 0.9 3.0 ± 1.0 2.4 ± 0.7 <0.001
HDL, mg/dL 1.4 ± 0.4 1.5 ± 1.1 1.4 ± 0.4 0.060
SBP, mm Hg 135 ± 16 134 ± 16 137 ± 16 0.4
DBP, mm Hg 77 ± 9 78 ± 8 77 ± 9 0.5
BMI, kg/m2 26.8 ± 3.7 26.0 ± 3.2 27.5 ± 3.9 0.017
CRP, mg/L 1.81 ± 1.7 1.72 ± 1.61 1.91 ± 1.77 0.3
WBCC, cells 109/L 6.1 ± 1.6 5.8 ± 1.6 6.4 ± 1.7 0.040
HRV SDNN, ms 44.3 ± 18.4 45.9 ± 17.9 42.7 ± 18.9 0.3
BRS Slope, ms/mm Hg 11.1 ± 6.8 12.8 ± 7.9 9.5 ± 5.1 0.022
Values expressed as counts for categorical variables and mean ± standard deviation (SD) for numerical variables. MI: Myocardial infarction, TC: Total
cholesterol, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, SBP; Systolic blood pressure, DBP: Diastolic blood pressure, BMI: Body mass
index, HR: Heart rate, CRP: C-reactive protein, WBCC: White blood cell count, BRS: Baroreflex sensitivity, HRV: Heart rate variability, SDNN: standard
deviation of RR interval.
a Subjects ever diagnosed with the disorder
*p-values for the difference between patients with or without prevalent CVD. BRS Slope, HRV SDNN, CRP, WBCC, carotid plaque area, total cholesterol,
LDL-cholesterol and HDL-cholesterol were logarithmically transformed in the analysis. However, untransformed data was presented as mean ± SD for all
variables for better comparison with data from other studies.
https://doi.org/10.1371/journal.pone.0174974.t001
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by 11% and still significantly associated with carotid plaque area (Table 2). Further, the stan-
dardized β-coefficient for BRS Slope, adjusted for CRP, was attenuated by 19%, and lost its sig-
nificance, whereas CRP was attenuated by 18% and still significantly associated with carotid
plaque area (Table 2). This suggests that low-grade inflammation could link the association
between BRS Slope and carotid plaque area.
Table 2. Relationships between parameters for autonomic function, inflammatory markers, atherosclerosis and clinical factors.
Variables Log carotid
plaque area
Log WBCC Log CRP
Univariate r p r p r p
CVD Risk Factors
Age, years 0.31 <0.001 0.21 0.019 0.11 0.2
Smoking 0.14 0.1 0.24 0.007 0,00 1.0
BMI, kg/m2 0.14 0.1 0.19 0.030 0.19 0.034
SBP, mm Hg 0.16 0.086 0.15 0.091 0.07 0.5
DBP, mm Hg -0.08 0.4 -0.11 0.2 -0.03 0.7
Log TC, mg/dL -0.08 0.4 -0.11 0.2 0.02 0.8
Log LDL, mg/dL -0.06 0.5 -0.15 0.085 0.03 0.7
Log HDL, mg/dL -0.11 0.2 -0.16 0.1 <0.00 1.0
Prevalent stroke/MI 0.30 <0.001 0.19 0.040 0.09 0.3
Diabetesa 0.08 0.4 0.11 0.2 0.10 0.3
Dyslipidemiaa -0.14 0.1 0.014 0.9 -0.14 0.1
Hypertensiona -0.01 0.9 -0.04 0.6 -0.15 0.1
Medication
Cholesterol-lowering 0.07 0.5 0.1 0.2 0.07 0.4
Antihypertensive 0.30 <0.001 0.18 0.040 0.08 0.4
Autonomic function
Log BRS Slope, ms/mm Hg -0.21 0.018 -0.29 0.001 -0.23 0.009
Log HRV SDNN, ms -0.16 0.081 -0.22 0.014 -0.13 0.2
Inflammation
Log WBCC, mg/L 0.36 <0.001 - - 0.27 0.003
Log CRP, mg/L 0.22 0.014 0.27 0.003 - -
2-predictor models β p
Log BRS Slope, ms/mm Hg -0.11 0.2
Log WBCC, mg/L 0.32 0.001
Log BRS Slope, ms/mm Hg -0.17 0.063
Log CRP, mg/L 0.18 0.047
Log HRV SDNN, ms -0.08 0.4
Log WBCC, mg/L 0.336 <0.001
Log HRV SDNN, ms -0.13 0.1
Log CRP, mg/L 0.206 0.023
r-values in univariate analysis are Pearson correlation coefficients and β-values in 2-predictor models are standardized regression coefficients. 2-predictor
models are multiple linear regressions including one variable of autonomic function and one variable of inflammation. CRP: C-reactive protein, WBCC:
White blood cell count, HRV: Heart rate variability, SDNN: standard deviation of RR interval, BRS: Baroreflex sensitivity, CVD: Cardiovascular disease, TC:
Total cholesterol, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, SBP; Systolic blood pressure, DBP: Diastolic blood pressure, BMI: Body
mass index, HR: Heart rate.
a Subjects ever diagnosed with the disorder
https://doi.org/10.1371/journal.pone.0174974.t002
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Independent relationships between reduced autonomic tone and
inflammation, and inflammation and atherosclerosis
Given the data suggesting a relationship between autonomic tone and inflammation, and
inflammation and atherosclerosis, we next investigated if these associations were independent
of other clinical variables and medical therapy. Three different multivariable regression models
were used to adjust for potential confounders. When adjusting for either age, or age and anti-
hypertensive medicine, the inverse associations between WBCC and both BRS Slope and HRV
SDNN, and the inverse association between CRP and BRS slope still remained significant
(Table 3, Model 1–2). Further, the associations between carotid plaque area and both WBCC
and CRP still remained significant (Table 3, Model 1–2). After adjusting for age, hypertensive
medicine, prevalent CVD, current smoking, BMI, diabetes, hypertension, dyslipidemia, sys-
tolic blood pressure and cholesterol-lowering medicine these associations remained significant
for all analysis except for the association between CRP and carotid plaque area (p = 0.093,
Table 3, Model 3).
When separately investigating patients on cholesterol-lowering medicine and untreated
patients, the interindividual associations between inflammatory parameters, carotid plaque
area and parameters for autonomic function still remained for both groups, except the associa-
tion between BRS Slope or HRV SDNN and WBCC, where the association was attenuated in
the untreated patients (data not shown). However, the correlations did not differ significantly
between treated and untreated patients.
Discussion
This population-based study showed an inverse association between BRS and atherosclerosis
and that WBCC could play an important role as a link in this relationship. Further, this study
contributes with new knowledge on the independent association between autonomic function
and WBCC, and between WBCC and atherosclerosis by demonstrating these relationships in
the same population. Thus, this study suggests inflammation as a mediator in the relationship
between reduced autonomic tone and atherosclerosis.
Autonomic dysfunction is a well-established risk factor for CVD [1–3], however the
mechanisms linking autonomic tone to CVD are still unknown. Previous studies suggest a
relationship between autonomic dysfunction and inflammation [4–7], as well as between
Table 3. Independent predictors of inflammation and atherosclerosis.
Predictor Respons Model 1 Model 2 Model 3
β p β p β p
Log BRS Slope, ms/mm Hg Log WBCC -0.25 0.005 -0.25 0.006 -0.25 0.004
Log HRV SDNN, ms -0.19 0.034 -0.18 0.047 -0.23 0.007
Log BRS Slope, ms/mm Hg Log CRP -0.22 0.017 -0.21 0.029 -0.23 0.013
Log HRV SDNN, ms -0.11 0.2 -0.1 0.3 -0.1 0.3
Log CRP, mg/L Log Plaque Area 0.2 0.024 0.18 0.038 0.14 0.093
Log WBCC, mg/L 0.3 <0.001 0.26 0.003 0.23 0.010
Model 1: Adjusted for age.
Model 2: Adjusted for age and antihypertensive medicine.
Model 3: Stepwise adjusted for prevalent CVD, current smoking, BMI, diabetes, hypertension, dyslipidemia, systolic blood pressure and cholesterol-
lowering medicine. Age and antihypertensive medicine were forced into the model.
Each predictor was included in separate regression models. β-values are standardized regression coefficients. BRS: Baroreflex sensitivity, HRV: Heart rate
variability, SDNN: standard deviation of RR intervals, WBCC: white blood cell count.
https://doi.org/10.1371/journal.pone.0174974.t003
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inflammation and atherosclerosis [9, 10]. These findings made us hypothesize that inflamma-
tion mediates the atherogenic effects of autonomic dysfunction. Few studies have investi-
gated the whole pathway (autonomic function—inflammation—atherosclerosis) in the same
population, or carotid atherosclerosis as the primary end-point. Intima media thickness
(IMT), a marker of preclinical atherosclerosis, was recently associated with increased CRP
and reduced HRV in patients suffering from depression [27]. This is partly in line with the
current study where we show an inverse association between autonomic function, measured
by BRS, and both WBCC and established carotid plaque lesions.
The association between autonomic function and carotid plaque area could be due to direct
effects of the autonomic nervous system on the progression of atherosclerosis, or mediated via
other factors. To test our hypothesis that reduced autonomic function could have an impact
on low-grade inflammation, which subsequently accelerates atherosclerosis, the association
between BRS Slope and atherosclerosis was adjusted for the inflammatory markers WBCC and
CRP. Interestingly, when adjusting for WBCC, the relationship between BRS and carotid pla-
que area was remarkably attenuated and no longer significant, demonstrating that WBCC
could be a mechanistic link in the association between reduced BRS and carotid plaque area.
However, even though adjustment for CRP also attenuates the association between reduced
BRS and carotid plaque area, the role of CRP may be interpreted with care since the effect was
less pronounced. Previous studies show a relationship between atherosclerosis and reduced
vessel distensibility, an effect that could have an impact on autonomic function. We cannot
rule out that aortic stiffness could affect autonomic function and previous studies both sup-
ports and oppose that reduced distensibility decreases BRS [28, 29]. Surprisingly, these studies
rarely adjust for low-grade inflammation, known to be associated with aortic stiffness [30, 31].
Regardless of the causative direction between autonomic function and atherosclerosis, our
data demonstrate that inflammation could play a role in this pathway.
Given that inflammatory markers might mediate the association between BRS and carotid
plaque area, we next investigate if autonomic function was independently associated with
inflammatory markers WBCC and CRP, and subsequently, if WBCC and CRP was indepen-
dently associated with carotid plaque area. The hypothesis of inflammation as a mechanistic
link between autonomic dysfunction and atherosclerosis derives from a number of different
studies displaying an inverse association between HRV and inflammatory markers, in both
patients with CVD [4–7], and in populations without CVD [32–36]. We confirm these rela-
tionships, demonstrating an association between HRV and WBCC in the current study. This
relationship is also extended by including another marker of autonomic function, BRS, also
demonstrating an independent association with both WBCC and CRP. In the current study,
only CRP and WBCC were used to assess inflammation. Given the perplexity of the inflamma-
tory process in atherosclerosis other inflammatory markers, such as cytokines, should be fur-
ther evaluated in future studies.
The relationship between inflammatory markers and CVD has been thoroughly character-
ized in previous studies. WBCC, a low-grade inflammatory marker has been an independent
predictor of CVD [12, 13], and associated with increased intima media thickness (IMT), as
well as femoral and carotid atherosclerosis [14–17]. Our results support these findings, show-
ing an association between WBCC and carotid plaque area, independent of other cardiovascu-
lar risk factors. Although, a large number of studies show CRP to be a strong predictor for
CVD [11] this association did not remain significant after adjusting for age, hypertensive med-
icine and other clinical risk factors in the current study. The role of CRP as an independent
predictor of the extent of atherosclerosis is debated, where some studies support this [18–20],
while other studies do not [14, 37, 38]. It is possible that the relationship between CRP and
CVD is more associated to the phenotype of atherosclerotic plaques [39–41], rather than the
Autonomic function, inflammation and atherosclerosis
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extent, which is the focus in the current study. Still, our results on inflammation and athero-
sclerosis confirm previous studies where carotid atherosclerosis was independently associated
with WBCC but not CRP [14].
Since cholesterol-lowering treatments influence both inflammation [42, 43], and athero-
sclerosis [44, 45], a sensitivity analysis for cholesterol-lowering treatment was conducted.
Although, most of the associations were coherent with the relationships in the whole popula-
tion, the fully adjusted associations between BRS Slope or HRV SDNN and WBCC were
reduced in the untreated patients (data not shown). However, the correlation in this smaller
group did not differ significantly from the treated group so the lack of association is possibly
due to lack of power.
In summary, in this study, men with prevalent CVD have reduced BRS, increased WBCC
and more carotid atherosclerosis compared to male subjects with no history of previous CVD.
We demonstrate that autonomic function is associated with atherosclerosis and that inflam-
mation could play an important role in mediating this relationship. Although this study dem-
onstrates that there is a relationship between autonomic dysfunction, inflammation and
atherosclerosis, the causal relationship between these parameters remains to be determined.
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